VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
GADOXETIC ACID
Preclinical
Small molecule
S
Seoul National University Hospital
1
Indications
2
Total Trials
0
Active Trials
0
Competitors
Clinical
Trials by Indication
[1]
Dyspnea
1 trial
Evaluation of Transient Dyspnea During Gadoxetic Acid Enhanced Multiphasic Liver MRI
Completed
·
S
Seoul National University Hospital
·
·
NCT02395991
·
60 enrolled
Hepatocellular Carcinoma
1 trial
Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive Diagnosis
Completed
·
S
Sara Varea
·
Phase 4
·
NCT01575574
·
74 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
2 trial records for GADOXETIC ACID. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
GADOXETIC ACID compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for GADOXETIC ACID. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Seoul National University Hospital company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
S
Seoul National University Hospital
Related News